Italian Prospective Data Collection for Better Patient Characterization in a Highly Treatment Experienced Population
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00614302 |
Recruitment Status
:
Completed
First Posted
: February 13, 2008
Last Update Posted
: October 2, 2009
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Data collection for better patient characterization in a highly treatment experienced population. Studying the clinical practice for the treatment of HIV multiexperienced patients in the real life.
The research will be divided into two phases:
- The first phase intends to define and understand the clinical practice using a questionnaire about general topics: definitions of multiexperienced patients and VL failure, therapeutic strategies and behaviour in particular cases.
- The second part of the research will collect the clinical data of double PIs failure patients.
Condition or disease | Intervention/treatment |
---|---|
HIV Infections | Drug: TPV |
Study Type : | Observational |
Actual Enrollment : | 428 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Italian Prospective Data Collection for Better Patient Characterization in a Highly Treatment Experienced Patient Population |
Study Start Date : | June 2007 |
Actual Primary Completion Date : | October 2008 |

- To study in the clinical practice the choice of a specific salvage regimen for multiexperienced patients. [ Time Frame: 48 weeks ]
- Reason of each VL failure or switching [ Time Frame: 48 weeks ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
Patients double PIs failure
Exclusion Criteria:

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00614302
Italy | |
Boehringer Ingelheim Investigational Site | |
Ancona, Italy | |
Boehringer Ingelheim Investigational Site | |
Bari, Italy | |
Boehringer Ingelheim Investigational Site | |
Benevento, Italy | |
Boehringer Ingelheim Investigational Site | |
Bisceglie, Italy | |
Boehringer Ingelheim Investigational Site | |
Bologna, Italy | |
Boehringer Ingelheim Investigational Site | |
Brescia, Italy | |
Boehringer Ingelheim Investigational Site | |
Busto, Italy | |
Boehringer Ingelheim Investigational Site | |
Caserta, Italy | |
Boehringer Ingelheim Investigational Site | |
Catania, Italy | |
Boehringer Ingelheim Investigational Site | |
Cremona, Italy | |
Boehringer Ingelheim Investigational Site | |
Firenze, Italy | |
Boehringer Ingelheim Investigational Site | |
Genova, Italy | |
Boehringer Ingelheim Investigational Site | |
Legnano, Italy | |
Boehringer Ingelheim Investigational Site | |
Milano, Italy | |
Boehringer Ingelheim Investigational Site | |
Napoli, Italy | |
Boehringer Ingelheim Investigational Site | |
Padova, Italy | |
Boehringer Ingelheim Investigational Site | |
Palermo, Italy | |
Boehringer Ingelheim Investigational Site | |
Pavia, Italy | |
Boehringer Ingelheim Investigational Site | |
Roma, Italy | |
Boehringer Ingelheim Investigational Site | |
Sassari, Italy | |
Boehringer Ingelheim Investigational Site | |
Torino, Italy |
Study Chair: | Boehringer Ingelheim | Boehringer Ingelheim |
Responsible Party: | Boehringer Ingelheim, Study Chair, Boehringer Ingelheim |
ClinicalTrials.gov Identifier: | NCT00614302 History of Changes |
Other Study ID Numbers: |
1182.130 |
First Posted: | February 13, 2008 Key Record Dates |
Last Update Posted: | October 2, 2009 |
Last Verified: | October 2009 |
Additional relevant MeSH terms:
HIV Infections Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases |
Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases |